多年来,亚洲日益成为全球临床研究的温床和目的地。一方面,越来越多的全球制药公司已经认识到将亚洲融入全球早期和晚期临床开发阶段的重要性和优势，同时亚洲临床研究市场被迅速改变的亚洲本地研发创新进一步推动和促进。
做为我们非常成功的临床试验峰会系列的一部分，本次峰会由Pan Asian Clinical Research Asociation,SAPA, Society for Clinical Trials协会共同支持，将在2014年11月19日和20日在上海博雅大酒店举办。届时将吸引超过180位临床研发领域的企业高层管理者参与，80%的参会者为总监级别以上职位。绝大多数参会者来自跨国或本土的制药企业、生物技术公司及医疗器械企业。相关政府官员、大学教授及中国顶级医院的研究者每年也竞相参与本会议。寻求新的商业合作机会并与行业同行们交流学习如何解决当前行业热点问题及挑战，如临床合作和外包策略;亚洲监管变革和市场准入;临床合作与技术创新，在临床运营中的最佳实践技术与项目管理;数据收集、质量与风险管理;并解决知识产权如何保护,药物安全,透明度和质量以及物流供应链等问题,保持和更新临床试验在该地区的增长速度与繁荣。
如果您期望与亚洲临床研发领域的决策者们会面及交流学习，这里将是您唯一正确的选择。令您及您的团队始终处于亚洲临床研究发展最前沿，尽在2014年11月19-20日的Asia临床试验领袖年会，期待您的参与！
届时峰会将有国际主题演讲，产业及学术报告，众多交流机会，将为高端科技及商业探讨打造一个互动的平台。我们欢迎阁下致电我们86-21-31602153获取更多信息，或把您的问题发送至我们电邮marketing@wbfgroup.com 。
Asia Clinical Trials Leaders Summit 2014
About ACTLS 2014
Over the years, Asia has increasingly become the hotbed and destination for the clinical research. From one side, increasingly global pharmaceutical companies have recognized the importance and advantages to integrate Asia into the global early and late phase clinical development but also meanwhile the Asian clinical research markets are further driven and facilitated by the rapidly transforming Asian Local R&D Innovation.
A part of our highly successful Clinical Trials series, the event supported by Pan Asian Clinical Research Asociation,SAPA, Society for Clinical Trials, which attracts over 180 attendees, will build upon ACTLS 2014 held in November 19thand 20th in Parkyard Hotel Shanghai ,China and examine partnerships and outsourcing strategies; key regulatory changes and the effects these have had on Asian market access; best practice techniques in clinical operations; Data Collection, Quality & Risk Management; and also address the need to protect intellectual property and ensure safety, transparency and quality as well as logistical hurdles so as to keep up to date with the pace of growth in the region and maintain the clinical trials boom in Asia.
With over 40 speakers and estimation to bring over 180 clinical professionals, the key congress topics will cover:
--- Asian Regulation , Development and outsourcing Strategies
--- Asian Clinical Operation and Project Management
--- Drug Safety, Clinical Data Collection and Management
--- Developing the Flexible, Strategic and Innovative Partnership
--- Novel Theories, Clinical Innovation and Quality Management
--- Novel Biomarkers, eClinical technology and Clinical Supply
--- Intellectual Property Protection and logistical hurdles
On behalf of the committee, we sincerely hope primary discussions, topics and invitees would come across your scientific and strategic interests and the whole summit will be consisted of keynote speeches, panel/roundtable discussions, open Q&A sessions, booth and poster exhibition and guided networking sessions for all professionals and management who are working for the drug development programs in Asia.
